510(k) K091522
K091522 is an FDA 510(k) premarket notification submitted by Immco Diagnostics, Inc. for the device "IMMULISA CELIAC G+ (GLIADIN) IGA AND IGG ANTIBODY ELISA". The FDA issued a decision of Substantially Equivalent on February 4, 2010. The device falls under product code MST (Antibodies, Gliadin), a Class II device regulated under 21 CFR 866.5750. Immco Diagnostics, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 4, 2010
- Date Received
- May 22, 2009
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antibodies, Gliadin
- Device Class
- Class II
- Regulation Number
- 866.5750
- Review Panel
- IM
- Submission Type